These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17575010)

  • 1. Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin.
    Laudi S; Trump S; Schmitz V; West J; McMurtry IF; Mutlak H; Christians U; Weimann J; Kaisers U; Steudel W
    Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L630-8. PubMed ID: 17575010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study.
    McMurtry MS; Bonnet S; Michelakis ED; Bonnet S; Haromy A; Archer SL
    Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L933-40. PubMed ID: 17675370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
    Ozturk EI; Uma S
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats.
    Xie L; Lin P; Xie H; Xu C
    Clin Exp Hypertens; 2010; 32(8):547-54. PubMed ID: 21091363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
    Rakotoniaina Z; Guerard P; Lirussi F; Rochette L; Dumas M; Goirand F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):241-51. PubMed ID: 18542928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
    Satoh M; Satoh A
    J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats.
    Gao YF; Zhu XD; Shi DM; Jing ZC; Li L; Ma D; Fan ZX; Li J; Wang YW; Wu BX
    Int J Mol Med; 2010 Oct; 26(4):541-7. PubMed ID: 20818494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
    Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
    Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
    Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
    Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.
    Nishimura T; Faul JL; Berry GJ; Vaszar LT; Qiu D; Pearl RG; Kao PN
    Am J Respir Crit Care Med; 2002 Nov; 166(10):1403-8. PubMed ID: 12406854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension.
    Meghwani H; Prabhakar P; Mohammed SA; Seth S; Hote MP; Banerjee SK; Arava S; Ray R; Maulik SK
    J Ethnopharmacol; 2017 Feb; 197():184-194. PubMed ID: 27401289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Simvastatin on 5-HT and 5-HTT in a Rat Model of Pulmonary Artery Hypertension.
    Jiang X; Yuan L; Li P; Wang J; Wang P; Zhang L; Sun B; Sun W
    Cell Physiol Biochem; 2015; 37(5):1712-24. PubMed ID: 26544069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats.
    Guignabert C; Raffestin B; Benferhat R; Raoul W; Zadigue P; Rideau D; Hamon M; Adnot S; Eddahibi S
    Circulation; 2005 May; 111(21):2812-9. PubMed ID: 15927991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the serotonin pathway as a therapeutic target for pulmonary hypertension.
    Gray EA; Tsuchimochi H; Pearson JT; Sonobe T; Fujii Y; Yoshimoto M; Umetani K; Shirai M; Schwenke DO
    J Synchrotron Radiat; 2013 Sep; 20(Pt 5):756-64. PubMed ID: 23955040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats.
    Liu B; Wang XQ; Yu L; Zhou TF; Wang XM; Liu HM
    Exp Lung Res; 2009 Jun; 35(5):411-26. PubMed ID: 19842842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
    Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
    Guignabert C; Izikki M; Tu LI; Li Z; Zadigue P; Barlier-Mur AM; Hanoun N; Rodman D; Hamon M; Adnot S; Eddahibi S
    Circ Res; 2006 May; 98(10):1323-30. PubMed ID: 16614302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
    Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of γ-aminobutyric acid on right ventricular pressure and pulmonary vascular remodeling in experimental pulmonary hypertension.
    Suzuki R; Maehara R; Kobuchi S; Tanaka R; Ohkita M; Matsumura Y
    Life Sci; 2012 Oct; 91(13-14):693-8. PubMed ID: 22542556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.